Introduction {#S0001}
============

Deranged autonomic nervous system (ANS) balance constitutes one of the numerous elements of the complex pathophysiological chronic heart failure (CHF) \[[@CIT0001]--[@CIT0004]\]. Most published studies indicate that well-planned exercise training, apart from improving the physical capacity, is also capable of positively affecting the modulation of the majority of parameters (although not necessarily the same ones) which reflect the ANS activity in CHF patients \[[@CIT0005]--[@CIT0007]\]. This results from the fact that different exercise training modalities have been applied in the existing studies. There are no papers evaluating the influence of telerehabilitation based on Nordic walking training on ANS activity in CHF patients. It needs to be stressed that during the Nordic walking training, patients use the majority of their muscles and obtain fitness building stimulation not present in cycling or simple walking training \[[@CIT0008]\]. Moreover, during this type of training patients also added a small resistance training component in the form of "grip and release" poles \[[@CIT0008]\]. Additionally, breathing and light stretching exercises in between Nordic walking sessions can be performed. The non-invasive assessment of indices reflecting ANS activity on the surface electrocardiogram (ECG) allow one to evaluate the efficacy of Nordic walking training in terms of sympathetic and parasympathetic balance \[[@CIT0009]\]. Therefore, the aim of this study was to assess the influence of Nordic walking training on ANS activity measured by heart rate variability (HRV) and heart rate turbulence (HRT) in CHF patients and its correlation with physical capacity improvement measured by peak oxygen consumption (peak VO~2~) evaluated in the cardiopulmonary exercise treadmill test (CPET).

Material and methods {#S0002}
====================

The present study formed part of a single-centre, prospective, parallel-group, randomized (2 : 1), controlled trial of home-based telemonitored Nordic walking training (training group (TG)) vs. usual care (control group (CG)) in CHF patients \[[@CIT0010]\] who also met the criteria for HRV and HRT evaluation. For this study, we recruited consecutive patients hospitalized between December 2009 and June 2012 in the Department of Cardiac Rehabilitation, Institute of Cardiology, Warsaw, Poland for inclusion in the cardiac rehabilitation. The study was approved by the local Ethics Committee. Each patient gave written informed consent.

We included: patients of either sex with any aetiology of left ventricular systolic CHF as defined in the European Society of Cardiology (ESC) guidelines \[[@CIT0001]\] diagnosed at least for 3 months; with a left ventricular ejection fraction (LVEF) \< 40% on echocardiography; classified by the New York Heart Association (NYHA) as class II or III; who were clinically stable and receiving an optimal and stable medication regimen for at least 4 weeks before enrolment; who had no contraindications to exercise training according to current recommendation for CHF patients \[[@CIT0011]\].

The exclusion criteria were: a history of an acute coronary syndrome within the last month, coronary artery bypass grafting (CABG) within the last 2 months, or initiation of cardiac resynchronization therapy within the last 6 months, or implantation of a pacemaker and/or implantable cardioverter-defibrillator (ICD) within the last 6 weeks; symptomatic and/or exercise-induced cardiac arrhythmia or conduction disturbances; valvular or congenital heart disease requiring surgical treatment; hypertrophic cardiomyopathy; severe pulmonary hypertension or other severe pulmonary disease; uncontrolled hypertension; anaemia; acute and/or decompensated non-cardiac disease; physical disability related to severe musculoskeletal or neurological problems; patient refusal to participate.

Autonomic nervous system activity assessment was conducted in the eligible patients who were in sinus rhythm. The exclusion criteria were: atrial fibrillation or flutter, atrial and/or ventricular pacing.

The qualified patients in both groups underwent the following assessments at entry and after completing the 8-week programme: clinical examination, two-dimensional echocardiography, 24-hour Holter ECG monitoring with HRV and HRT evaluation, and CPET.

Echocardiography {#S20003}
----------------

Two-dimensional echocardiography was performed using standard parasternal, apical, and subcostal views (VIVID 4 GE Medical System with a 2.5 MHz transducer). Left ventricular ejection fraction was calculated from conventional apical two-chamber and four-chamber images using the biplane Simpson technique.

24-hour Holter ECG monitoring and indices of autonomic nervous system activity analysis {#S20004}
---------------------------------------------------------------------------------------

The HRV and HRT were measured using a 24-hour Holter ECG, recorded with a 3-channel Spacelabs Lifecard system (Spacelabs, Del Mar Reynolds, Hertford, UK). The HRV indices were calculated after prospective interactive ECG analysis, using the Impresario Space software (Del Mar Reynolds). The measurements of HRV included time domain -- standard deviation of all normal RR intervals (SDNN) -- and frequency domain indices.

The frequency domain indices were calculated after fast Fourier transformation of five 10-minute ECG segments, recorded between 2 a.m. and 6 a.m. The highest and lowest values were excluded, and the three remaining values were averaged. The power spectrum density of low frequency (LF) 0.04--0.15 Hz, high frequency (HF) 0.15--0.4 Hz, and the low frequency to high frequency ratio (LF/HF) was calculated using standard methodology \[[@CIT0009]\].

The measurements of HRT included turbulence onset (TO) and turbulence slope (TS) according to the algorithm described by Schmidt *et al*. \[[@CIT0012]\]. Parameters of HRT were considered normal when TO \< 0%, and TS \> 2.5 ms/RR interval. The influence of Nordic walking training on ANS activity was assessed by changes (delta) in SDNN, LF, HF, LF/HF ratio, TO and TS resulting from the comparison of these parameters from the beginning and the end of the programme.

Cardiopulmonary exercise treadmill test {#S20005}
---------------------------------------

The symptom limited CPET according to a ramp protocol \[[@CIT0013]\] and ESC guidelines \[[@CIT0014]\] was performed using a Schiller treadmill (Carrollton, USA) which was connected to a computerized breath-by-breath spiroergometry system (ZAN 600, ZAN Messgeräte GmbH, Germany). Oxygen consumption was measured continuously using breath-by-breath analysis and used as an index of exercise capacity. Peak VO~2~ was defined as the highest oxygen uptake level achieved during the final 30 s of CPET.

Exercise training {#S20006}
-----------------

Exercise training was planned in line with the current guidelines for CHF patients \[[@CIT0011]\]. The chosen workload reflected individual effort tolerance with regard to: perceived exertion according to the Borg scale \[[@CIT0015]\] and the training heart rate (HR) range established individually for each patient. The training HR was calculated using the method known as HR reserve. This method uses a percentage of the difference between the maximum HR and the resting HR rate, and adds this value to the resting HR. The target training HR was 40--70% of the HR reserve. Following the baseline evaluation, patients underwent some (3--6) monitored educational exercise training sessions. Subsequently, patients underwent an 8-week home-based telerehabilitation programme. The training session consisted of three parts: a warm-up lasting 5--10 min (breathing and light resistance exercises, calisthenics), a 15--45 min Nordic walking training, and a 5-minute cool-down. The initial duration of the aerobic Nordic walking training depended on the functional capacity in baseline CPET. If baseline peak VO~2~ was \< 14 ml/kg/min, we started at 10 min of Nordic walking/day, if baseline peak VO~2~ was 14--20 ml/kg/min, we started at 15 min of Nordic walking/day; and if baseline peak VO~2~ was \> 20 ml/kg/min, we started at 20 min of Nordic walking/day. Later on we tended to gradually prolong the time allotted to training so that the final period of time would reach 45--60 min. In order to achieve this optimal prolonged training duration usually 2 weeks needed to elapse. Patients trained five times a week.

The exercise training effectiveness was assessed by changes (delta) in peak VO~2~ in CPET, resulting from the comparison of these parameters from the beginning and the end of the programme. The methodology of the telerehabilitation model was described previously \[[@CIT0016]--[@CIT0018]\].

In brief, all patients in the TG received a special remote device for ECG and telesupervised exercise training -- the telerehabilitation set (Pro Plus Company, Poland), which consists of: an EHO mini device and blood pressure measuring and weighing machine. The EHO mini device enabled the ECG data from three pre-cordial leads to be recorded and transmitted via a mobile phone to the monitoring centre.

Usual care {#S20007}
----------

Patients in CG receiving "usual care" did not receive a formal exercise training prescription and did not undergo supervised rehabilitation. All patients, independent from the treatment group, were given recommendations for appropriate lifestyle changes and self-management according to ESC guidelines \[[@CIT0001]\].

Statistical analysis {#S20008}
--------------------

Statistical analyses were performed using SAS software (version 9.2; Cary, NC, USA). The normality of distributions was verified using the Shapiro-Wilk test. To compare normally distributed continuous variables, paired and unpaired *t-*tests were used. To compare changes of variables in time between training and control groups the general linear model with repeated measures adjusted for age and NYHA class was used. The signed-rank test (for changes over time) and the Wilcoxon test (to compare groups) were used for continuous variables that were not distributed normally. Correlations between peak VO~2~ and LF/HF ratio changes were tested with the Spearman-Pearson test. The χ^2^ or Fisher exact test was used for categorical variables. Values of *p* \< 0.05 were considered significant.

Results {#S0009}
=======

Of the 111 patients randomized, 77 were assigned to the TG and 34 to the CG. Thirty-six patients in the TG and 15 patients in the CG were eligible for HRV analysis. The groups were comparable in terms of demographic data, baseline clinical parameters and pharmacotherapy except for age and NYHA class. It needs to be stressed that all patients were treated with a β-blocker. The baseline clinical characteristics of patients are shown in [Table I](#T0001){ref-type="table"}.

###### 

Baseline characteristics

  Characteristics                             Training group (*n* = 36)   Control group (*n* = 15)   Value of *p*
  ------------------------------------------- --------------------------- -------------------------- --------------
  Males                                       31 (86)                     15 (100)                   NS
  Age \[years\]                               52.6 ±10.12                 61.4 ±13.2                 0.0205
  Left ventricular ejection fraction (%)      32 ±7                       33 ±8                      NS
  Etiology of heart failure:                                                                         
   Ischaemic                                  25 (69.4)                   12 (80.0)                  NS
   Non-ischaemic                              11 (30.6)                   3 (20.0)                   NS
  Past medical history:                                                                              
   Myocardial infarction                      24 (66.7)                   12 (80.0)                  NS
   Angioplasty                                18 (50.0)                   10 (66.7)                  NS
   Coronary artery bypass grafting            6 (11.8)                    4 (26.7)                   NS
   Stroke                                     1 (2.9)                     1 (6.7)                    NS
   Diabetes                                   8 (22.2)                    4 (26.67)                  NS
   Hyperlipidaemia                            19 (52.8)                   8 (53.3)                   NS
  Functional status:                                                                                 
   NYHA II                                    32 (88.9)                   8 (53.3)                   0.009
   NYHA III                                   4 (11.1)                    7 (46.7)                   0.009
  Heart rate variability:                                                                            
   SDNN \[ms\]                                118 ±30                     124 ±32                    NS
   Low frequency \[ms^2^/Hz\]                 532 ±601                    339 ±211                   NS
   High frequency \[ms^2^/Hz\]                392 ±493                    225 ±154                   NS
   Low-to-high frequency ratio                1.91 ±1.11                  2.2 ±1.6                   NS
  Heart rate turbulence:                                                                             
   Turbulence onset (%)                       --1.51 ±3.12                --1.31 ±1.13               NS
   Turbulence slope \[ms/RR interval\]        9.04 ±10.29                 5.43 ±5.01                 NS
  Cardiopulmonary exercise test:                                                                     
   Peak VO~2~ \[ml/kg/min\]                   16.98 ±4.02                 17.90 ±3.61                NS
  Treatment:                                                                                         
   β-Blocker                                  36 (100)                    15 (100)                   NS
   Angiotensin converting enzyme inhibitors   32 (88.9)                   13 (86.7)                  NS
   Angiotensin receptor blockers              4 (11.1)                    1 (6.7)                    NS
   Loop diuretics                             19 (52.8)                   8 (53.3)                   NS
   Aspirin                                    29 (80.6)                   11 (73.3)                  NS
   Anticoagulants                             8 (22.2)                    4 (26.7)                   NS
   Statins                                    28 (77.8)                   11 (73.3)                  NS
   Implantable cardioverter-defibrillator     24 (66.7)                   9 (60.0)                   NS

Data presented are mean ± SD or n (%), NS -- non-significant, NYHA -- New York Heart Association class, SDNN -- standard deviation of all normal RR intervals, peak VO~2~ -- peak oxygen consumption.

Effects of Nordic walking training on autonomic nervous system indices {#S20010}
----------------------------------------------------------------------

There was a significant improvement in sympathovagal balance evaluated by LF/HF ratio only in the TG (*p* = 0.0001), which was statistically significant in between-group analysis after adjustment for age and NYHA class (*p* = 0.0038). The HRT did not change significantly in either group. The details are presented in [Table II](#T0002){ref-type="table"}.

###### 

Comparison of outcomes before and after telerehabilitation based on Nordic walking training in the training group (*p*^1^) and before and after observation in the control group (*p*^2^) and between groups -- group × time adjusted for age and New York Heart Association class (*p*^3^)

  Parameter               Training group   Control group   Value of *p*^3^                                      
  ----------------------- ---------------- --------------- ----------------- -------------- -------------- ---- --------
  SDNN \[ms\]             118 ±30          119.5 ±31       NS                124 ±32        123 ±25        NS   NS
  LF \[ms^2^/Hz\]         532 ±601         440 ±572        NS                339 ±211       699 ±1112      NS   NS
  HF \[ms^2^/Hz\]         392 ±493         482 ±535        NS                225 ±154       386 ±540       NS   NS
  LF/HF                   1.91 ±1.11       1.07 ±0.63      0.0001            2.2 ±1.6       2.46 ±1.6      NS   0.0038
  TO (%)                  --1.51 ±3.12     --2.14 ±2.69    NS                --1.31 ±1.13   --1.99 ±1.50   NS   NS
  TS \[ms/RR interval\]   9.04 ±10.29      8.88 ±7.16      NS                5.43 ±5.01     5.98 ±3.23     NS   NS

Data presented are mean values ± SD; statistical significance: p \< 0.05; NS -- non-significant, SDNN -- standard deviation of all normal RR intervals; LF -- low frequency, HF -- high frequency; low-to-high frequency ratio; TO -- turbulence onset, TS -- turbulence slope.

Effectiveness of Nordic walking training {#S20011}
----------------------------------------

Nordic walking training resulted in a significant improvement in functional capacity assessed by peak VO~2~ (16.98 ±4.02 vs. 19.70 ±4.36 ml/kg/min, *p* \< 0.0001). In the CG we did not observe significant changes in peak VO~2~ (17.90 ±3.61 vs. 17.72 ±3.95, *p* = 0.7805). Between-group analysis showed that the differences between TG and CG were statistically significant in terms of Δpeak VO~2~, after adjustment for age and NYHA class (*p* = 0.0081) ([Figure 1](#F0001){ref-type="fig"}).

![Changes in peak oxygen consumption (peak VO~2~) within training and control groups and between those groups](AMS-11-26367-g001){#F0001}

Additionally, an inverse correlation was found between the decrease in ΔLF/HF and the increase in Δpeak VO~2~ (*R* = --0.3830, *p* = 0.0211) only in the TG ([Figure 2](#F0002){ref-type="fig"}). There was no correlation observed between these parameters in the CG (*R* = --0.2163, *p* = 0.4387) ([Figure 3](#F0003){ref-type="fig"}).

![Correlation between the change in peak oxygen consumption (Δpeak VO~2~) and the change in low-to-high frequency ratio (ΔLF/HF) in training group](AMS-11-26367-g002){#F0002}

![Correlation between the change in peak oxygen consumption (Δpeak VO~2~) and the change in low-to-high frequency ratio (ΔLF/HF) in control group](AMS-11-26367-g003){#F0003}

Discussion {#S0012}
==========

The main and novel finding of our study is that in CHF patients, home-based telemonitored Nordic walking training leads to the improvement of the balance of the ANS components assessed by LF/HF ratio and physical capacity evaluated by peak VO~2~ in CPET. Moreover, the changes in peak VO~2~ were significantly correlated with the changes in LF/HF ratio. In the TG, individual ANS parameters (SDNN, LF, HF) indicated positive yet non-significant statistical trends (decreased LF, increased HF), but in consequence, final balance of the ANS components (LF/HF) improved significantly.

For this reason, it is clear that the positive yet statistically non-significant changes of individual ANS parameters which caused a significant influence on the parasympathetic-sympathetic balance can be considered as one of the pleiotropic (i.e. multifactorial, broader) effects of Nordic walking training. These favourable changes were not observed in the CG. The HRT did not change significantly in either the training or the control group. It needs to be stressed that before and after the 8-week Nordic walking training/observation the TO and TS values were within the norm in both groups. The varied response to Nordic walking in terms of HRV and HRT can be explained by the fact that ANS indices analyzed in this study reflect different components of the ANS. While HRV reflects its spontaneous activity, HRT reflects the response of baroreflex receptor activity provoked by ventricular premature beats. So far, only one study focused on HRT after rehabilitation in CHF patients has been published and our observations are concordant with this specific study \[[@CIT0019]\].

It is clear that the ANS reaction to exercise training depends on the ANS dysfunction level prior to rehabilitation. For the results of our study it is essential that both groups were comparable in terms of analyzed parameters responsible for ANS activity precisely prior to the intervention and, for this reason, the improvement of parasympathetic-sympathetic balance after the rehabilitation in the TG as compared to the CG can be considered reliable and valid.

Few studies of CHF patients showed favourable effects on HRV after cardiac rehabilitation. Although published studies have evaluated the influence of exercise training on ANS, the influence of Nordic walking training on HRV and HRT has not yet been assessed in any study. The majority of published data indicates that endurance aerobic training significantly increases SDNN \[[@CIT0020]--[@CIT0023]\]. Nevertheless, Selig *et al*. did not find any difference after moderate-intensity resistance exercise training in the time domain (SDNN) but observed significant improvement in LF/HF ratio \[[@CIT0024]\]. Our results are consistent with these outcomes. Coats *et al*., on the other hand, reported that exercise training improved exercise tolerance, increased HRV and reduced whole body norepinephrine spillover in CHF patients \[[@CIT0021]\]. Kiilavuori *et al*. showed that rehabilitation increased high frequency HRV in patients suffering from CHF \[[@CIT0025]\]. Their findings support the hypothesis that exercise training modulates autonomic derangement in CHF by increasing parasympathetic tone. Radaelli *et al*. found that sympathetic modulation of peripheral vessels is diminished in CHF but significantly improved following the rehabilitation \[[@CIT0026]\]. The training appears to impart beneficial changes in autonomic control in CHF patients through both increased sympathetic control of peripheral vessels and parasympathetic control of heart rate \[[@CIT0026]\].

Malfato *et al*. observed greater restoration of ANS responsiveness to vagal and sympathetic stimulation in CHF patients after 3 months of a low-intensity rehabilitation programme. Moreover, the authors reported significant improvement not only in ANS activity but also in peak VO~2~ \[[@CIT0027]\]. In contrast to our study there was no correlation between the amount of improvement in exercise capability (expressed as % change in peak VO~2~) and the amount of change in autonomic responsiveness (expressed as changes in LF/HF during controlled respiration or during standing) \[[@CIT0027]\]. Also Murad *et al*. reported that the improvement in HRV did not correlate with measures of exercise capacity \[[@CIT0028]\]. Similarly, our study proved that there were no positive effects in patients who did not undergo the exercise training.

The studies conducted so far evaluated various parameters (time domain and/or frequency domain indices) reflecting ANS activity. Individual parameters have not always been improved, yet the sympathetic-parasympathetic balance was restored, which indicated that exercise training increases vagal tone and reduces sympathetic cardiac influence, resulting in the improvement in HRV. On the whole, all the studied exercise modalities such as supervised aerobic endurance and resistance training and home-based rehabilitation improved HRV among CHF patients \[[@CIT0019]--[@CIT0032]\].

The findings to date imply that exercise training exerts an influence on HRV favourable modulation of sympathetic/parasympathetic balance (via increasing vagal modulation and decreasing sympathetic tone). Further research is needed to identify the training protocols which would produce optimal improvements in HRV and HRT. This research should encompass the assessment of the following variables: training type (endurance/resistance/strength/respiratory), intensity (aerobic/anaerobic), method (continuous/interval), duration (time of session), frequency (number of sessions per day/per week) application (systemic/regional), control (supervised/telesupervised/unsupervised), progression (consider low level initially/increase if tolerated) and setting (hospital/out-patient/home-based) \[[@CIT0002]--[@CIT0004], [@CIT0011], [@CIT0033]\].

For this reason, additional studies comparing the influence of different training modalities on ANS activity on larger patient groups are necessary.

The limitations include the fact that our study was part of a single centre trial. Due to the nature of the intervention, the study was not blinded. The study group was not very large. Only a few women participated in the study; therefore our outcomes cannot be fully extrapolated to the female population.

The duration of Nordic walking training in our study was relatively short -- only 8 weeks. We did not exclude patients who underwent CABG, in whom afferent and efferent cardiac innervations might have been impaired. We also did not exclude patients suffering from diabetes mellitus and hypertension in whom ANS might have been affected by these diseases. Nevertheless, both training and control groups were comparable in terms of CABG, diabetes mellitus and hypertension.

In conclusion, Nordic walking showed positive effects as far as the parasympathetic-sympathetic balance in CHF patients of NYHA class II and III was concerned, yet no significant changes in HRT were observed. This positive balance change correlates with the improvement of physical capacity resulting from home-based telemonitored Nordic walking training modality. Our results demonstrate that different processes modulate HRV and HRT, which offers additional information about ANS activity. The 8-week Nordic walking training was nevertheless unsuccessful in terms of completely normalizing the ANS function.

The study was supported by the National Science Centre, Poland -- grant number NN404 107936.

Conflict of interest {#S0013}
====================

The authors declare no conflict of interest.
